Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$384M |
| 2 |
Mondelez International
MDLZ
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
Johnson & Johnson
JNJ
|
+$105M |
| 5 |
Church & Dwight Co
CHD
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$276M |
| 2 |
Apple
AAPL
|
+$180M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$73.6M |
| 5 |
Broadcom
AVGO
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 9.83% |
| 3 | Utilities | 6.25% |
| 4 | Real Estate | 4.8% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Biote Corp
BTMD
$42.7M
| $232K | ﹤0.01% |
+41,563
| New | +$277K |
|
1427
CS Disco
LAW
$277M
| $229K | ﹤0.01% |
38,876
-13,617
| -26% | -$75.9K |
|
1428
Center Bancorp
CNOB
$1.62B
| $227K | ﹤0.01% |
+9,080
| New | +$209K |
|
|
1429
CALL
Amazon
AMZN
$2.83T
| $223K | ﹤0.01% |
+1,200
| New | +$219K |
|
|
1430
PUT
Amazon
AMZN
$2.83T
| $223K | ﹤0.01% |
1,200
-1,387,700
| -100% | -$253M |
|
1431
Radiant Logistics
RLGT
$392M
| $222K | ﹤0.01% |
+34,531
| New | +$210K |
|
|
EWCZ
1432
DELISTED
European Wax Center
EWCZ
| $221K | ﹤0.01% |
32,442
-59,274
| -65% | -$460K |
|
1433
Relmada Therapeutics
RLMD
$471M
| $220K | ﹤0.01% |
+68,000
| New | +$220K |
|
1434
3D Systems Corp
DDD
$522M
| $219K | ﹤0.01% |
+77,230
| New | +$222K |
|
1435
Aspen Aerogels
ASPN
$418M
| $218K | ﹤0.01% |
+7,857
| New | +$197K |
|
1436
Crane Co
CR
$12B
| $217K | ﹤0.01% |
+1,370
| New | +$206K |
|
1437
Redwire
RDW
$2.89B
| $217K | ﹤0.01% |
+31,627
| New | +$209K |
|
1438
CEVA Inc
CEVA
$749M
| $216K | ﹤0.01% |
+8,931
| New | +$194K |
|
1439
Medallion Financial
MFIN
$269M
| $215K | ﹤0.01% |
+26,357
| New | +$209K |
|
1440
Verastem
VSTM
$611M
| $215K | ﹤0.01% |
+72,061
| New | +$196K |
|
1441
Cass Information Systems
CASS
$733M
| $214K | ﹤0.01% |
+5,148
| New | +$213K |
|
1442
CALL
Capri Holdings
CPRI
$1.56B
| $212K | ﹤0.01% |
5,000
| – | – |
|
1443
Nokia
NOK
$55.8B
| $212K | ﹤0.01% |
48,528
+15,092
| +45% | +$61.1K |
|
1444
Enpro
NPO
$6.52B
| $212K | ﹤0.01% |
+1,305
| New | +$203K |
|
|
ESGR
1445
DELISTED
Enstar Group
ESGR
| $211K | ﹤0.01% |
655
-734
| -53% | -$238K |
|
1446
CALL
Procter & Gamble
PG
$340B
| $208K | ﹤0.01% |
+1,200
| New | +$204K |
|
1447
Dentsply Sirona
XRAY
$2.2B
| $208K | ﹤0.01% |
+7,696
| New | +$197K |
|
|
AFCG
1448
AFC Gamma
AFCG
$77.5M
| $207K | ﹤0.01% |
+20,226
| New | +$195K |
|
1449
Similarweb
SMWB
$755M
| $207K | ﹤0.01% |
+23,405
| New | +$185K |
|
1450
Lifecore Biomedical
LFCR
$170M
| $205K | ﹤0.01% |
+41,529
| New | +$217K |
|
Similar funds
Michael Gelband's Q3 2024 Portfolio in Review
As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.
- Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
- Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
- Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
- Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
- Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
- Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
- Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.